Researcher.Life Logo

ACS Medicinal Chemistry Letters : Impact Factor & More

eISSN: 1948-5875pISSN: 1948-5875

Aims and Scope of ACS Medicinal Chemistry Letters

ACS Medicinal Chemistry Letters is a peer-reviewed academic journal in the field of medicinal chemistry. Founded in 2009, this online journal is published monthly by the American Chemical Society. The Editor-in-Chief is Dennis C. Liotta (Emory University, Atlanta, Georgia, USA). Less

Key Metrics

CiteScore
6.6
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q2Biochemistry
SNIP
0.93
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on ACS Medicinal Chemistry Letters

ACS Medicinal Chemistry Letters Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher AMER CHEMICAL SOC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in ACS Medicinal Chemistry Letters ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ACS Medicinal Chemistry Letters

Perspectives of Patents in Academic and Industrial Collaborations in Drug Discovery
  • 29 Dec 2025
  • ACS Medicinal Chemistry Letters
Novel Imidazopyridazine Compounds as IL-17 Inhibitors for Treating Inflammatory Diseases
  • 28 Dec 2025
  • ACS Medicinal Chemistry Letters
Probing the Chemical Space of Polymerase Theta with Nucleotide Analogues Bearing a Stereogenic All-Carbon Quaternary Center
  • 24 Dec 2025
  • ACS Medicinal Chemistry Letters
Selective 7-Azaindole Modulators Targeting Fyn and GSK-3β for Dual-Target Neuromodulation
  • 24 Dec 2025
  • ACS Medicinal Chemistry Letters
First-in-Class Potent, Dual HDAC6/Proteasome Inhibitors Lacking a Hydroxamic Acid Motif: Discovery of Novel Anti-Multiple Myeloma Agents
  • 22 Dec 2025
  • ACS Medicinal Chemistry Letters
Improving Anticancer Activity of Doxorubicin by 4′- <i>epi</i> -Dehydroxyamination
  • 22 Dec 2025
  • ACS Medicinal Chemistry Letters
Perspectives of Patents in Academic and Industrial Collaborations in Drug Discovery
  • 29 Dec 2025
  • ACS Medicinal Chemistry Letters
Novel Imidazopyridazine Compounds as IL-17 Inhibitors for Treating Inflammatory Diseases
  • 28 Dec 2025
  • ACS Medicinal Chemistry Letters
Probing the Chemical Space of Polymerase Theta with Nucleotide Analogues Bearing a Stereogenic All-Carbon Quaternary Center
  • 24 Dec 2025
  • ACS Medicinal Chemistry Letters
Selective 7-Azaindole Modulators Targeting Fyn and GSK-3β for Dual-Target Neuromodulation
  • 24 Dec 2025
  • ACS Medicinal Chemistry Letters
First-in-Class Potent, Dual HDAC6/Proteasome Inhibitors Lacking a Hydroxamic Acid Motif: Discovery of Novel Anti-Multiple Myeloma Agents
  • 22 Dec 2025
  • ACS Medicinal Chemistry Letters
Improving Anticancer Activity of Doxorubicin by 4′- <i>epi</i> -Dehydroxyamination
  • 22 Dec 2025
  • ACS Medicinal Chemistry Letters

FAQs on ACS Medicinal Chemistry Letters